Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Oct:168:108449.
doi: 10.1016/j.diabres.2020.108449. Epub 2020 Sep 17.

Hyperglycemia, glucocorticoid therapy, and outcome of COVID-19

Mario Luca Morieri  1 , Gian Paolo Fadini  2 , Federico Boscari  1 , Paola Fioretto  1 , Alberto Maran  1 , Luca Busetto  1 , Maria Cristina Crepaldi  1 , Monica Vedovato  1 , Benedetta Maria Bonora  1 , Elisa Selmin  1 , Gaetano Arcidiacono  1 , Silvia Pinelli  1 , Filippo Farnia  1 , Daniele Falaguasta  1 , Lucia Russo  1 , Giacomo Voltan  1 , Sara Mazzocut  1 , Giorgia Costantini  1 , Francesca Ghirardini  1 , Silvia Tresso  1 , Anna Maria Cattelan  1 , Andrea Vianello  1 , Roberto Vettor  1 , Angelo Avogaro  1
Affiliations
Comment

Hyperglycemia, glucocorticoid therapy, and outcome of COVID-19

Mario Luca Morieri et al. Diabetes Res Clin Pract. 2020 Oct.
No abstract available

Keywords: Glucose; Metabolism; Prediction; SARS-CoV-2; Steroid; Survival.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Association between admission fasting plasma glucose (FPG) and COVID-19 severity by use of glucocorticoids before or during hospitalization. Estimates were adjusted for age and sex. *Data on in hospital-use of steroids was not available for two patients.
See this image and copyright information in PMC

Comment on

References

    1. Fadini G.P., Morieri M.L., Boscari F., Fioretto P., Maran A., Busetto L. Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration. Diab Res Clin Pract. 2020;168:108374. - PMC - PubMed
    1. Singh A.K., Singh R. Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19. Diab Res Clin Pract. 2020;108382 - PMC - PubMed
    1. Fadini G.P., Morieri M.L., Longato E., Avogaro A. Prevalence and impact of diabetes among people infected with SARS-CoV-2. J Endocrinol Invest. 2020;43:867–869. - PMC - PubMed
    1. Zhu B., Jin S., Wu L., Hu C., Wang Z., Bu L. J-shaped association between fasting blood glucose levels and COVID-19 severity in patients without diabetes. Diab Res Clin Pract. 2020;168:108381. - PMC - PubMed
    1. Ceriello A. Hyperglycemia and COVID-19: what was known and what is really new? Diab Res Clin Pract. 2020;108383 - PMC - PubMed

Substances